Journal article
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
- Abstract:
-
BACKGROUND: Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of this study was to assess prospectively the drug's ability to prevent type 2 diabetes in individuals at high risk of developing the condition. METHODS: 5269 adults aged 30 years or more with impaired fasting glucose or impaired glucose tolerance, or both, and no previous cardiovascular disease were recruited from 191 sites in 21 countries and randomly assigned to r...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Lancet
- Volume:
- 368
- Issue:
- 9541
- Pages:
- 1096-1105
- Publication date:
- 2006-09-01
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Source identifiers:
-
9805
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:9805
- UUID:
-
uuid:cd2e1eac-c698-4bec-915b-af6f73be9a05
- Local pid:
- pubs:9805
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2006
If you are the owner of this record, you can report an update to it here: Report update to this record